A curcumin-diglutaric acid conjugated prodrug with improved water solubility and antinociceptive properties compared to curcumin

References

• El-Magboub A, Rojsitthisak P, Muangnoi C, et al. Biological targets and pharmacology of curcumin. In: Pouliquen DL, editor. Curcumin: synthesis, emerging role in pain management and health implications. New York (NY): Nova Science; 2014. p. 103–134.
   Google Scholar
• Chattapadhyay I, Biswas K, Bandyopadhyay U, et al. Turmeric and curcumin: biological actions and medicinal applications. Curr Sci. 2004;87:44–53.
   Web of Science ®Google Scholar
• Buadonpri W, Wichitnithad W, Rojsitthisak P, et al. Synthetic curcumin inhibits carrageenan-induced paw edema in rats. J Health Res. 2009;23:11–16.
   Google Scholar
• Sinha D, Biswas J, Sung B, et al. Chemopreventive and chemotherapeutic potential of curcumin in breast cancer. Curr Drug Targets. 2012;13(14):1799–1819.10.2174/138945012804545632
   PubMed Web of Science ®Google Scholar
• Epstein J, Sanderson IR, MacDonald TT. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr. 2010;103:1545–1557.10.1017/S0007114509993667
   PubMed Web of Science ®Google Scholar
• Mishra S, Narain U, Mishra R, et al. Design, development and synthesis of mixed bioconjugates of piperic acid-glycine, curcumin-glycine/alanine and curcumin-glycine-piperic acid and their antibacterial and antifungal properties. Bioorg Med Chem. 2005;13:1477–1486.10.1016/j.bmc.2004.12.057
   PubMed Web of Science ®Google Scholar
• Reddy RC, Vatsala PG, Keshamouni VG, et al. Curcumin for malaria therapy. Biochem Biophys Res Commun. 2005;326:472–474.10.1016/j.bbrc.2004.11.051
   PubMed Web of Science ®Google Scholar
• Hatcher H, Planalp R, Cho J, et al. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65:1631–1652.10.1007/s00018-008-7452-4
   PubMed Web of Science ®Google Scholar
• Ratnatilaka Na Bhuket P, El-Magboub A, Haworth IS, et al. Enhancement of curcumin bioavailability via the prodrug approach: challenges and prospects. Eur J. Drug Metab Pharmacokinet. 2017;42:341–353.10.1007/s13318-016-0377-7
   PubMed Web of Science ®Google Scholar
• Garrett E. Prediction of stability in pharmaceutical Preparations X. J Pharm Sci. 1962;51:445–450.10.1002/jps.2600510511
   PubMed Web of Science ®Google Scholar
• Brent DA, Chandrasurin P, Ragouzeos A, et al. Rearrangement of chloramphenicol-3-monosuccinate. J Pharm Sci. 1980;69:906–908.10.1002/jps.2600690812
   PubMed Web of Science ®Google Scholar
• Johansen M, Larsen C. Stability and kinetics of hydrolysis of metronidazole monosuccinate in aqueous solution and in plasma. Int J Pharm. 1984;21:201–209.10.1016/0378-5173(84)90094-2
   Google Scholar
• Wichitnithad W, Nimmannit U, Callery PS, et al. Effects of different carboxylic ester spacers on chemical stability, release characteristics, and anticancer activity of mono-PEGylated curcumin conjugate. J Pharm Sci. 2011;100:5206–5218.10.1002/jps.22716
   PubMed Web of Science ®Google Scholar
• Wichitnithad W, Nimmannit U, Wacharasindhu S, et al. Synthesis, characterization and biological evaluation of succinate prodrugs of curcuminoids for colon cancer treatment. Molecules. 2011;16:1888–1900.10.3390/molecules16021888
   PubMed Web of Science ®Google Scholar
• Testa B, Mayer JM. Design of intramolecularly activated prodrugs. Drug Metab Rev. 1998;30(4):787–807.10.3109/03602539808996330
   PubMed Web of Science ®Google Scholar
• Wongsrisakul J, Wichitnithad W, Rojsitthisak P, et al. Antinociceptive effects of curcumin diethyl disuccinate in animal model. J Health Res. 2010;24:175–180.
   Google Scholar
• Ozawa H, et al. Curcumin β-D-Glucuronide Plays an Important Role to Keep High Levels of Free-Form Curcumin in the Blood. Biol Pharm Bull. 2017;40(9):1515–1524.10.1248/bpb.b17-00339
   PubMed Web of Science ®Google Scholar
• Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK. Improved HPLC method for the determination of curcumin, demethoxycurcumin, and bisdemethoxycurcumin. J Agric Food Chem. 2002;50:3668–3672.10.1021/jf025506a
   PubMed Web of Science ®Google Scholar
• OECD. Test No. 105: Water Solubility. Paris: OECD Publishing; 1995.
   Google Scholar
• OECD. Test No. 107: Partition Coefficient (n-octanol/water): Shake Flask Method. Paris: OECD Publishing; 1995.
   Google Scholar
• Boonyarikpunchai W, Sukrong S, Towiwat P. Antinociceptive and anti-inflammatory effects of rosmarinic acid isolated from Thunbergia laurifolia Lindl. Pharmacol Biochem Behav. 2014;124:67–73.10.1016/j.pbb.2014.05.004
   PubMed Web of Science ®Google Scholar
• Raja K, Alonso A, Banerjee P, et al. Curcumin derivatives. United States Patent US 9,650.404 B2. 2017 May 16.
   Google Scholar
• Déciga-Campos M, Mata R, Rivero-Cruz I. Antinociceptive pharmacological profile of Dysphania graveolens in mouse. Biomed Pharmacother. 2017;89:933–938.10.1016/j.biopha.2017.02.096
   PubMed Web of Science ®Google Scholar
• Keyhanfar F, et al. Evaluation of antinociceptive effect of pregabalin in mice and its combination with tramadol using tail flick test. Iran J Pharm Res. 2013;12(3):483–493.
   PubMed Web of Science ®Google Scholar
• Yu LX, et al. Biopharmaceutics classification system: The scientific basis for biowaiver extensions. Pharma Res. 2002;19(7):921–925.10.1023/A:1016473601633
   Google Scholar
• Grynkiewicz G, Slifirski P. Curcumin and curcuminoids in quest for medicinal status. Acta Biochimica Polonica. 2012;59:201–212.
   PubMed Web of Science ®Google Scholar
• Pawar YB, Munjal B, Arora S, et al. Bioavailability of a lipidic formulation of curcumin in healthy human volunteers. Pharmaceutics. 2012;4:517–530.10.3390/pharmaceutics4040517
   PubMedGoogle Scholar
• Gomes P, Vale N, Moreira R. Cyclization-activated prodrugs. Molecules. 2007;12(11):2484–2506.10.3390/12112484
   PubMed Web of Science ®Google Scholar
• Fredholt K, Mørk N, Begtrup M. Hemiesters of aliphatic dicarboxylic acids as cyclization-activated prodrug forms for protecting phenols against first-pass metabolism. Int J Pharm. 1995;123(2):209–216.10.1016/0378-5173(95)00062-N
   Google Scholar
• Li B, Sedlacek M, Manoharan I, et al. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem Pharmacol. 2005;70:673–1684.
   Web of Science ®Google Scholar